Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells

Metformin is a widely prescribed anti-diabetes drug with potential utilities for cancer therapies. Several studies have related metformin to the reduced risk of cholangiocarcinoma (CCA), highlighting its potentialities for the treatments of CCA. However, the underlying molecular mechanisms remain el...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, Hang, Caihua, Jiang, Ting, Yi, Shenghui, Shao, Wei, Li, Wengang, Lin, Donghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735195/
https://www.ncbi.nlm.nih.gov/pubmed/33330044
http://dx.doi.org/10.3389/fonc.2020.570516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735195/
https://www.ncbi.nlm.nih.gov/pubmed/33330044
http://dx.doi.org/10.3389/fonc.2020.570516

Ejemplares similares